Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of 451.00 billion. The enterprise value is 448.48 billion.
| Market Cap | 451.00B |
| Enterprise Value | 448.48B |
Important Dates
The last earnings date was Wednesday, November 6, 2024.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | Aug 15, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.86% |
| Shares Change (QoQ) | -0.11% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.17B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.77, with an EV/FCF ratio of 38.57.
| EV / Earnings | 31.66 |
| EV / Sales | 11.79 |
| EV / EBITDA | 24.77 |
| EV / EBIT | 26.61 |
| EV / FCF | 38.57 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 0.47.
| Current Ratio | 0.94 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | 0.44 |
| Debt / FCF | 0.73 |
| Interest Coverage | 788.08 |
Financial Efficiency
Return on equity (ROE) is 88.73% and return on invested capital (ROIC) is 50.41%.
| Return on Equity (ROE) | 88.73% |
| Return on Assets (ROA) | 21.47% |
| Return on Capital (ROIC) | 50.41% |
| Revenue Per Employee | 563,010 |
| Profits Per Employee | 197,089 |
| Employee Count | 64,319 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 1.23 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.24% in the last 52 weeks. The beta is 0.15, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.15 |
| 52-Week Price Change | -0.24% |
| 50-Day Moving Average | 116.00 |
| 200-Day Moving Average | 127.76 |
| Relative Strength Index (RSI) | 39.59 |
| Average Volume (20 Days) | 40,576 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of 40.47 billion and earned 14.17 billion in profits. Earnings per share was 3.17.
| Revenue | 40.47B |
| Gross Profit | 34.26B |
| Operating Income | 17.92B |
| Pretax Income | 17.84B |
| Net Income | 14.17B |
| EBITDA | 19.05B |
| EBIT | 17.92B |
| Earnings Per Share (EPS) | 3.17 |
Balance Sheet
The company has 11.20 billion in cash and 8.52 billion in debt, giving a net cash position of 2.68 billion.
| Cash & Cash Equivalents | 11.20B |
| Total Debt | 8.52B |
| Net Cash | 2.68B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 18.03B |
| Book Value Per Share | 4.05 |
| Working Capital | -1.97B |
Cash Flow
In the last 12 months, operating cash flow was 17.68 billion and capital expenditures -6.05 billion, giving a free cash flow of 11.63 billion.
| Operating Cash Flow | 17.68B |
| Capital Expenditures | -6.05B |
| Free Cash Flow | 11.63B |
| FCF Per Share | n/a |
Margins
Gross margin is 84.66%, with operating and profit margins of 44.27% and 35.01%.
| Gross Margin | 84.66% |
| Operating Margin | 44.27% |
| Pretax Margin | 44.07% |
| Profit Margin | 35.01% |
| EBITDA Margin | 47.08% |
| EBIT Margin | 44.27% |
| FCF Margin | 28.73% |
Dividends & Yields
This stock pays an annual dividend of 0.52, which amounts to a dividend yield of 0.49%.
| Dividend Per Share | 0.52 |
| Dividend Yield | 0.49% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 46.60% |
| Buyback Yield | 0.86% |
| Shareholder Yield | 1.35% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 10.08.
| Altman Z-Score | 10.08 |
| Piotroski F-Score | n/a |